Unknown

Dataset Information

0

Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients.

ABSTRACT:

SUBMITTER: Chen L 

PROVIDER: S-EPMC8089097 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients.

Chen Lei L   Abou-Alfa Ghassan K GK   Zheng Bo B   Liu Jing-Feng JF   Bai Jian J   Du Lu-Tao LT   Qian Yun-Song YS   Fan Rong R   Liu Xiao-Long XL   Wu Lin L   Hou Jin-Lin JL   Wang Hong-Yang HY  

Cell research 20210215 5

Similar Datasets

Unknown Assessment of Circulating Tumor DNA for Early Detection of Hepatocellular Carcinoma in Alpha-Fetoprotein-Negative Patients With Cirrhotic Nodules.
| S-EPMC12748524 | biostudies-literature
Unknown Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.
| S-EPMC9292132 | biostudies-literature
Unknown Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients.
| S-EPMC4650428 | biostudies-literature
Genomics High-sensitive circulating microRNA panel for early detection of hepatocellular carcinoma
2020-08-03 | GSE113740 | GEO
Unknown Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma.
| S-EPMC11791606 | biostudies-literature
Unknown Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection.
| S-EPMC11416236 | biostudies-literature
Unknown A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma.
| S-EPMC10557228 | biostudies-literature
Unknown Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
| S-EPMC7195221 | biostudies-literature
Unknown Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma.
| S-EPMC9120881 | biostudies-literature
Unknown Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level.
| S-EPMC8986837 | biostudies-literature